Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients with COVID-19 (BIRCH): a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
Streinu-Cercel et al., Clinical Infectious Diseases, doi:10.1093/cid/ciaf406
https://c19early.org/streinucercel2.html